Back
FirstEnergy Vs. Sarepta Therapeutics Industry Stock Comparison
Buy
60
FE
FirstEnergy
Last Price:
$39.80
Seasonality Move:
3.51%
Sell
50
SRPT
Sarepta Therapeutics
Last Price:
$73.40
Seasonality Move:
14.66%
Buy
60
FirstEnergy (FE)
is a Buy
Is FirstEnergy a Buy, Sell or Hold?
-
The current FirstEnergy [FE] share price is $39.56. The Score for FE is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
-
FE is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
50
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $79.97. The Score for SRPT is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FE Stock Price Chart
What is FirstEnergy's stock price today?
-
The FirstEnergy share price today is $39.56The current trend is relatively stagnant and FE is experiencing selling pressure, which indicates risk of future bearish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $79.97Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing buying pressure, which is a positive indicator for future bullish movement.
FE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.24 | Sell |
Relative Strength Index (14 RSI): | 48.61 | Sell |
Chaikin Money Flow: | -2467753 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (38.62 - 41.56) | Sell |
Bollinger Bands (100): | (39.22 - 42) | Sell |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -6.65 | Sell |
Relative Strength Index (14 RSI): | 30.31 | Sell |
Chaikin Money Flow: | 3301090 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (94.25 - 111.51) | Sell |
Bollinger Bands (100): | (105.8 - 127.52) | Sell |
FE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 39.27 | Buy |
20-day SMA: | 40.05 | Sell |
50-day SMA: | 39.91 | Sell |
200-day SMA: | 41.1 | Sell |
8-day EMA: | 39.5 | Buy |
20-day EMA: | 39.69 | Sell |
50-day EMA: | 40.03 | Sell |
200-day EMA: | 40.45 | Sell |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 94.24 | Sell |
20-day SMA: | 101.11 | Sell |
50-day SMA: | 110.69 | Sell |
200-day SMA: | 125.58 | Sell |
8-day EMA: | 91.61 | Sell |
20-day EMA: | 99.38 | Sell |
50-day EMA: | 107.77 | Sell |
200-day EMA: | 119.29 | Sell |
FirstEnergy Earnings Growth & FE Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.07 per share, a decrease next quarter of $0.29 per share, a decrease this year of $0.06 per share, and an increase next year of $0.23 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.52 per share, a decrease next quarter of $0.64 per share, an increase this year of $5.33 per share, and an increase next year of $5.23 per share.
FirstEnergy Technical Analysis
Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Mar 5 | Mar 6 | Mar 7 | Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
05 | 06 | 07 | 11 | 12 | 13 | 14 | 17 | 18 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |